Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Real World Evidence: Time for a Switch?

Sobel RE, Bate A, Reynolds RF.

Drug Saf. 2018 Dec;41(12):1309-1312. doi: 10.1007/s40264-018-0739-y. No abstract available.

PMID:
30302624
2.

Do FDA label changes work? Assessment of the 2010 class label change for proton pump inhibitors using the Sentinel System's analytic tools.

Sobel RE, Bate A, Marshall J, Haynes K, Selvam N, Nair V, Daniel G, Brown JS, Reynolds RF.

Pharmacoepidemiol Drug Saf. 2018 Mar;27(3):332-339. doi: 10.1002/pds.4392. Epub 2018 Feb 2.

PMID:
29392851
3.
4.

Pregabalin prescriptions in the United Kingdom: a drug utilisation study of The Health Improvement Network (THIN) primary care database.

Asomaning K, Abramsky S, Liu Q, Zhou X, Sobel RE, Watt S.

Int J Clin Pract. 2016 May;70(5):380-8. doi: 10.1111/ijcp.12791. Epub 2016 Mar 29.

PMID:
27028939
5.

Current needs in pediatric pharmacoepidemiology.

Lasky T, Artaman A, Czaja AS, Maruti SS, Osokogu OU, Verhamme KM, Sobel RE.

Pharmacoepidemiol Drug Saf. 2016 Jun;25(6):738-42. doi: 10.1002/pds.3985. Epub 2016 Feb 22.

PMID:
26910571
6.

Computer-assisted expert case definition in electronic health records.

Walker AM, Zhou X, Ananthakrishnan AN, Weiss LS, Shen R, Sobel RE, Bate A, Reynolds RF.

Int J Med Inform. 2016 Feb;86:62-70. doi: 10.1016/j.ijmedinf.2015.10.005. Epub 2015 Oct 31.

PMID:
26725697
7.

Novel method to collect medication adverse events in juvenile arthritis: results from the childhood arthritis and rheumatology research alliance enhanced drug safety surveillance project.

Ringold S, Hendrickson A, Abramson L, Beukelman T, Blier PR, Bohnsack J, Chalom EC, Gewanter HL, Gottlieb B, Hollister R, Hsu J, Hudgins A, Ilowite NT, Klein-Gitelman M, Lindsley C, Lopez Benitez JM, Lovell DJ, Mason T, Milojevic D, Moorthy LN, Nanda K, Onel K, Prahalad S, Rabinovich CE, Ray L, Rouster-Stevens K, Ruth N, Shishov M, Spalding S, Syed R, Stoll M, Vehe RK, Weiss JE, White AJ, Wallace CA, Sobel RE.

Arthritis Care Res (Hoboken). 2015 Apr;67(4):529-37. doi: 10.1002/acr.22487.

8.

Safety of celecoxib and nonselective nonsteroidal anti-inflammatory drugs in juvenile idiopathic arthritis: results of the Phase 4 registry.

Sobel RE, Lovell DJ, Brunner HI, Weiss JE, Morris PW, Gottlieb BS, Chalom EC, Jung LK, Onel KB, Petiniot L, Goldsmith DP, Nanda K, Shishov M, Abramsky S, Young JP, Giannini EH; Pediatric Rheumatology Collaborative Study Group.

Pediatr Rheumatol Online J. 2014 Jul 16;12:29. doi: 10.1186/1546-0096-12-29. eCollection 2014.

9.

Using registries to identify adverse events in rheumatic diseases.

Lionetti G, Kimura Y, Schanberg LE, Beukelman T, Wallace CA, Ilowite NT, Winsor J, Fox K, Natter M, Sundy JS, Brodsky E, Curtis JR, Del Gaizo V, Iyasu S, Jahreis A, Meeker-O'Connell A, Mittleman BB, Murphy BM, Peterson ED, Raymond SC, Setoguchi S, Siegel JN, Sobel RE, Solomon D, Southwood TR, Vesely R, White PH, Wulffraat NM, Sandborg CI.

Pediatrics. 2013 Nov;132(5):e1384-94. doi: 10.1542/peds.2013-0755. Epub 2013 Oct 21. Review.

10.

Monitoring the long-term safety of therapies for children with juvenile idiopathic arthritis: time for a consolidated patient registry.

Smith MY, Sobel RE, Wallace CA.

Arthritis Care Res (Hoboken). 2010 Jun;62(6):800-4. doi: 10.1002/acr.20128. No abstract available.

11.

Integrating evidence from multiple sources to evaluate post-approval safety: an example of sildenafil citrate and cardiovascular events.

Sobel RE, Reynolds RF.

Curr Med Res Opin. 2008 Jul;24(7):1861-8. doi: 10.1185/03007990802128781 . Epub 2008 May 27.

PMID:
18507892
12.

Cardiovascular outcomes among sildenafil users: results of the International Men's Health Study.

Mittleman MA, Maclure M, Lewis MA, Hall GC, Moore N, Giuliano F, Porst H, Hedelin H, Martin-Morales A, Sobel RE, Reynolds R, Glasser DB.

Int J Clin Pract. 2008 Mar;62(3):367-73. doi: 10.1111/j.1742-1241.2007.01679.x.

PMID:
18261073
13.

NAION and treatment of erectile dysfunction: reply from Pfizer.

Sobel RE, Cappelleri JC.

Br J Ophthalmol. 2006 Jul;90(7):927. No abstract available.

14.

Sildenafil citrate use and the incidence of nonarteritic anterior ischemic optic neuropathy.

Gorkin L, Hvidsten K, Sobel RE, Siegel R.

Int J Clin Pract. 2006 Apr;60(4):500-3.

15.

Molecular analysis and characterization of PrEC, commercially available prostate epithelial cells.

Sobel RE, Wang Y, Sadar MD.

In Vitro Cell Dev Biol Anim. 2006 Jan-Feb;42(1-2):33-9.

PMID:
16618209
16.

Cell lines used in prostate cancer research: a compendium of old and new lines--part 2.

Sobel RE, Sadar MD.

J Urol. 2005 Feb;173(2):360-72. Review.

PMID:
15643173
17.

Cell lines used in prostate cancer research: a compendium of old and new lines--part 1.

Sobel RE, Sadar MD.

J Urol. 2005 Feb;173(2):342-59. Review.

PMID:
15643172
19.

Unique gene organization: alternative splicing in Drosophila produces two structurally unrelated proteins.

Mottus RC, Whitehead IP, O'Grady M, Sobel RE, Burr RH, Spiegelman GB, Grigliatti TA.

Gene. 1997 Oct 1;198(1-2):229-36.

PMID:
9370286
20.

Fc gammaRIIA polymorphism as a risk factor for invasive pneumococcal infections in systemic lupus erythematosus.

Yee AM, Ng SC, Sobel RE, Salmon JE.

Arthritis Rheum. 1997 Jun;40(6):1180-2. No abstract available.

PMID:
9182932
21.

Reduced levels of histone H3 acetylation on the inactive X chromosome in human females.

Boggs BA, Connors B, Sobel RE, Chinault AC, Allis CD.

Chromosoma. 1996 Dec;105(5):303-9.

PMID:
8939823
22.

Transcription-linked acetylation by Gcn5p of histones H3 and H4 at specific lysines.

Kuo MH, Brownell JE, Sobel RE, Ranalli TA, Cook RG, Edmondson DG, Roth SY, Allis CD.

Nature. 1996 Sep 19;383(6597):269-72.

PMID:
8805705
23.

Efficient transcriptional silencing in Saccharomyces cerevisiae requires a heterochromatin histone acetylation pattern.

Braunstein M, Sobel RE, Allis CD, Turner BM, Broach JR.

Mol Cell Biol. 1996 Aug;16(8):4349-56.

24.

Population norms for serum ferritin.

Custer EM, Finch CA, Sobel RE, Zettner A.

J Lab Clin Med. 1995 Jul;126(1):88-94.

PMID:
7602240
25.

Conservation of deposition-related acetylation sites in newly synthesized histones H3 and H4.

Sobel RE, Cook RG, Perry CA, Annunziato AT, Allis CD.

Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):1237-41.

26.
27.

Gingival and bacterial plaque response to instrumentation, oral hygiene instruction and nutritional therapy.

Jones BW Jr, Scott TE, Coleman JR Jr, Clark JW, Morse PK, Sobel RE.

J Periodontol. 1985 Sep;56(9):558-61.

PMID:
3861844
28.

Subchronic ocular and systemic toxicity of topically applied delta 9-tetrahydrocannabinol.

Green K, Sobel RE, Fineberg E, Wynn HR, Bowman KA.

Ann Ophthalmol. 1981 Oct;13(10):1219-22. No abstract available.

PMID:
6274239
29.

The acute toxicity of high doses of systemically administered formocresol in dogs.

Myers DR, Pashley DH, Whitford GM, Sobel RE, McKinney RV.

Pediatr Dent. 1981 Mar;3(1):37-41. No abstract available.

PMID:
6951149
30.

Chronic renal insufficiency from cortical necrosis induced by arsenic poisoning.

Gerhardt RE, Hudson JB, Rao RN, Sobel RE.

Arch Intern Med. 1978 Aug;138(8):1267-9.

PMID:
677984
31.

Betamethasone-17-benzoate in the treatment of recurrent aphthous ulcers.

Merchant HW, Gangarosa LP, Glassman AB, Sobel RE.

Oral Surg Oral Med Oral Pathol. 1978 Jun;45(6):870-5.

PMID:
355966
32.

Zinc sulfate supplementation for treatment of recurring oral ulcers.

Merchant HW, Gangarosa LP, Glassman AB, Sobel RE.

South Med J. 1977 May;70(5):559-61.

PMID:
870981
33.

Kidney preservation by hypothermic perfusion with albumin versus plasma and with pulsatile versus non-pulsatile flow.

Abouna GM, Pashley DH, Ginsbury JM, Delong TG, Sobel RE, Jeske AH.

Br J Surg. 1974 Jul;61(7):555-61. No abstract available.

PMID:
4846149
34.

Proceedings: Critical evaluation of viability assays in renal preservation.

Abouna GM, Delong TG, Pashley DH, Sobel RE, Ginsburg JM, Woodruff M.

Br J Surg. 1974 Apr;61(4):325. No abstract available.

PMID:
4598984
35.

Massive early proteinuria following renal homotransplantation.

Abouna GM, Kogure H, Porter KA, Andres GA, Lutcher CL, Sobel RE.

JAMA. 1973 Nov 5;226(6):631-5. No abstract available.

PMID:
4585337
36.

Physiological variations in serum triglycerides.

Savory J, Sobel RE.

Ann Clin Lab Sci. 1972 Mar-Apr;2(2):126-31. No abstract available.

PMID:
4681724
37.

Ox brain aminopeptidases. Further purification of three bovine enzymes.

Sobel RE, Brecher AS.

Can J Biochem. 1971 Jun;49(6):676-85. No abstract available.

PMID:
5569580
38.

Automated procedure for simultaneously measuring total globulin and total protein in serum.

Savory J, Heintges MG, Sobel RE.

Clin Chem. 1971 Apr;17(4):301-6. No abstract available.

39.

The hydrolytic activity in normal human and malignant tissue.

Brecher AS, Pugatch RD, König M, Wasilauskas VP Jr, Suszkiw JB, Sobel RE.

Proc Soc Exp Biol Med. 1969 Jul;131(3):828-31. No abstract available.

PMID:
4307235
40.

Studies on ox brain aminopeptidases.

Brecher AS, Sobel RE.

Biochem J. 1967 Nov;105(2):641-6.

41.

The proteolytic activity in brain.

Brecher AS, Oliphant BB, Sobel RE.

Arch Int Physiol Biochim. 1966 Jun;74(3):429-34. No abstract available.

PMID:
4162223

Supplemental Content

Loading ...
Support Center